7. Challenges ??
Monitoring of Sensitized PatientsAwaitingTransplantation
• Circulating antibodies must be periodically monitored in patients awaiting
transplantation
• Variable response to desensitization therapies
• Antibodies can rebound following completion of a course of treatment
• Further sensitizing events may take place
8. Sensitised Patient ??
A sentitised patient is one who is having HLA antibodies circulating
in the body.
HLA antibodies are not naturally occurring but arise from the
following :
PREGNANCY
TRANSFUSION
PREVIOUS TRANSPLANTATION
9. Post Transplant Monitoring
Pre-transplant desensitization may reduce the alloantibody burden sufficiently to
allow transplantation to proceed with a negative cytotoxic crossmatch
Concern for a post-transplant rebound in antibody levels and subsequent risk of
delayed acute rejection
10. Goals of Flowcytometric Assays in
Transplantation
• Identify Presence Of HLA antibodies
• Determine the titre of Antibodies
• Identify the DSA (Donor Specific Antibodies)
• Planning appropriate transfusion support strategies
• Elucidates the specificities (i.e. HLA antigens) to which they react
11. Cell Based
FlowcytometricAssays
Very Sensitive
Lacks Specificity
Uses Cell as base element
to study
E.g. Flowcytometric
Crossmatch
Solid phase
FlowcytometricAssays
Uses Microparticles coated with
purified HLA molecules
Very Specific/ PreciseAssay
Widely Used
E.g. Flow PRA
12. Role of Flowcytometry
Elementary flow cytometric investigations have been employed to;
Quantify cell numbers eg.Absolute CD3+T cells counts
Population Ratios eg. CD4+:CD8+ ratios
Activation status of different cellular subsets eg. Expression of CD69/HLADR on CD3+ or
CD8+T cells
13. Role of Flowcytometry
Elevated frequencies of CD4+Tregs in patients post transplant have been reliably
correlated with reduced risk of graft rejection
Other regulatoryT cells subsets have been identified by flowcytometry like
CD8+/CD28 –
Less is known about these regulatory cells role in inducing tolerance
14. Advantages Of Flowcytometry In Organ
Transplantation
Enhanced sensitivity offered by indirect fluorescence effectively compensates for low titre
antibodies
Use of subset specific monoclonal antibodies permits the electronic dissection of cell
subpopulations for the identification of both class I and class II antibodies
Ability of flow cytometer to detect antibody independently of complement fixation
Wider assay of clinically relevant immunoglobulins
Improved specificity of assay